Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.
| Image |  |
|---|---|
| Description | scientific article published on 02 July 2016 |
| Author/s |
author: Marco Colleoni Andrea Vingiani Elisabetta Munzone Aron Goldhirsch Karen L Price Giuseppe Viale Giancarlo Pruneri Thomas Ruhstaller Carmen Criscitiello Roswitha Kammler Meredith M Regan Giuseppe Curigliano |
| Publication date | July 2, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |